| Generic Name |
Brand name |
Breast cancer stage |
Breast cancer subtype |
Type of therapy |
Where in the drug approval process is this treatment |
| Abemaciclib |
Verzenio |
Stage IV (metastatic) |
HR+ |
Targeted therapy |
Health Canada - Approved |
| Abemaciclib (with an Aromatase Inhibitor) |
Verzenio |
Stage IV (metastatic) |
HR+ |
Targeted therapy |
PCPA - Provincial & territorial price negotiation |
| Abemaciclib (with endocrine therapy) |
Verenzio |
Stage I, Stage II, Stage III |
HR+ |
Targeted therapy |
Listed on Provincial/Territorial drug Formulary |
| Abemaciclib (with fulvestrant) |
Verzenio |
Stage IV (metastatic) |
HR+ |
Targeted therapy |
PCPA - Provincial & territorial price negotiation |
| Alpelisib |
Piqray |
Stage IV (metastatic) |
HR+ |
Targeted therapy |
PCPA - Provincial & territorial price negotiation |
| Anastrozole |
Arimidex |
Stage 0, Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+ |
Hormone therapy |
Listed on Provincial/Territorial drug Formulary |
| Atezolizumab |
Tecentriq |
Stage IV (metastatic) |
Triple Negative |
Targeted therapy |
Health Canada - Approved |
| Capecitabine |
Xeloda, and various generic versions |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Capivasertib |
Truqap |
Stage IV (metastatic) |
HR+ |
Targeted therapy |
Listed on Provincial/Territorial drug Formulary |
| Carboplatin |
Paraplatin |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Cisplatin |
Platinol, and various generic versions |
Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Cyclophosphamide |
Cytoxan, and various generic versions |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Docetaxel |
Taxotere, and various generic versions |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Doxorubicin |
Adriamycin, and various generic versions |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Entrectinib |
Rozlytrek |
Stage IV (metastatic) |
Tumour-agnostic (any cancer type) |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Epirubicin |
Pharmorubicin, and various generic versions |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Eribulin |
Halaven |
Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Everolimus |
Afinitor |
Stage IV (metastatic) |
HR+ |
Targeted therapy |
Listed on Provincial/Territorial drug Formulary |
| Exemestane |
Aromasin, and various generic versions |
Stage 0, Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+ |
Hormone therapy |
Listed on Provincial/Territorial drug Formulary |
| Fluorouracil Injection |
Fluorouracil Injection, and various generic versions |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Fulvestrant |
Faslodex |
Stage IV (metastatic) |
HR+ |
Hormone therapy |
Listed on Provincial/Territorial drug Formulary |
| Gemcitabine |
Gemzar, and various generic versions |
Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Goserelin 10.8mg |
Zoladex |
Stage 0, Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+ |
Hormone therapy |
Listed on Provincial/Territorial drug Formulary |
| Goserelin 3.6mg |
Zoladex |
Stage 0, Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+ |
Hormone therapy |
Listed on Provincial/Territorial drug Formulary |
| Inavolisib |
Itovebi |
Stage IV (metastatic) |
HR+ |
Targeted therapy |
CDA/INNESSS - Public funding review process |
| Lapatinib |
Tykerb |
Stage IV (metastatic) |
HER2+ |
Targeted therapy |
Listed on Provincial/Territorial drug Formulary |
| Larotrectinib |
Vitrakvi |
Stage IV (metastatic) |
Tumour-agnostic (any cancer type) |
Targeted therapy |
Listed on Provincial/Territorial drug Formulary |
| Letrozole |
Femara, and various generic versions |
Stage 0, Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+ |
Hormone therapy |
Listed on Provincial/Territorial drug Formulary |
| Leuprolide |
Lupron, and various generic versions |
Stage 0, Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+ |
Hormone therapy |
Listed on Provincial/Territorial drug Formulary |
| Megestrol |
Megace, and various generic versions |
Stage IV (metastatic) |
HR+ |
Hormone therapy |
Listed on Provincial/Territorial drug Formulary |
| Methotrexate |
Metoject |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Mitoxantrone |
Novantrone |
Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| nab-Paclitaxel |
Abraxane, and various generic versions |
Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Neratinib |
Nerlynx |
Stage I, Stage II, Stage III |
HR+, HER2+ |
Targeted therapy |
PCPA - Provincial & territorial price negotiation |
| Olaparib |
Lynparza |
Stage IV (metastatic) |
HR+, Triple Negative |
Targeted therapy |
Health Canada - Approved |
| Olaparib |
Lynparza |
Stage I, Stage II, Stage III |
HR+, Triple Negative |
Targeted therapy |
Listed on Provincial/Territorial drug Formulary |
| Paclitaxel |
Taxol |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |
| Palbociclib (with an Aromatase Inhibitor) |
Ibrance, and various generic versions |
Stage IV (metastatic) |
HR+ |
Targeted therapy |
Listed on Provincial/Territorial drug Formulary |
| Palbociclib (with Fulvestrant) |
Ibrance, and various generic versions |
Stage IV (metastatic) |
HR+ |
Targeted therapy |
Listed on Provincial/Territorial drug Formulary |
| Pegylated Liposomal Doxorubicin |
Caelyx, and various generic versions |
Stage IV (metastatic) |
HR+, HER2+, Triple Negative |
Chemotherapy |
Listed on Provincial/Territorial drug Formulary |